Bank Of New York Mellon Corp Alaunos Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$0.04 - $0.13 $0 - $0	1 Added 0.0%	102,692 $7.26 Million
Q3 2023 Oct 24, 2023	BUY	$0.12 - $0.5 $2 - $9	19 Added 0.02%	102,691 $13.5 Million
Q1 2023 May 09, 2023	BUY	$0.46 - $0.81 $47,229 - $83,164	102,672 New	102,672 $64.7 Million
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $51,336 - $26.8 Million	102,672 New	102,672 $66,000
Q3 2022 Nov 14, 2022	SELL	$1.04 - $322.5 $2,017 - $625,650	-1,940 Reduced 1.85%	102,672 $177,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $238,854 - $722,389	-582,572 Reduced 84.78%	104,612 $130,000
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $767 - $1,330	704 Added 0.1%	687,184 $749,000
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $66,300 - $125,694	46,042 Added 7.19%	686,480 $1.25 Million
Q2 2021 Aug 11, 2021	SELL	$2.63 - $3.67 $936,795 - $1.31 Million	-356,196 Reduced 35.74%	640,438 $1.69 Million
Q1 2021 May 13, 2021	BUY	$2.82 - $5.6 $253,010 - $502,431	89,720 Added 9.89%	996,634 $3.59 Million
Q4 2020 Feb 09, 2021	SELL	$2.09 - $3.09 $35,935 - $53,129	-17,194 Reduced 1.86%	906,914 $2.29 Million
Q3 2020 Nov 12, 2020	SELL	$2.39 - $3.43 $1,957 - $2,809	-819 Reduced 0.09%	924,108 $2.33 Million
Q2 2020 Aug 12, 2020	BUY	$2.2 - $3.71 $205,680 - $346,851	93,491 Added 11.24%	924,927 $3.03 Million
Q1 2020 May 06, 2020	BUY	$1.9 - $4.98 $272,532 - $714,321	143,438 Added 20.85%	831,436 $2.04 Million
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $163,138 - $220,960	41,301 Added 6.39%	687,998 $3.25 Million
Q3 2019 Nov 07, 2019	BUY	$4.13 - $6.94 $3,361 - $5,649	814 Added 0.13%	646,697 $2.77 Million
Q2 2019 Aug 12, 2019	BUY	$3.98 - $6.2 $279,571 - $435,512	70,244 Added 12.2%	645,883 $3.77 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $4.4 $7,670 - $16,874	3,835 Added 0.67%	575,639 $2.22 Million
Q4 2018 Feb 11, 2019	SELL	$1.61 - $3.62 $46,588 - $104,751	-28,937 Reduced 4.82%	571,804 $1.07 Million
Q3 2018 Nov 09, 2018	SELL	$2.26 - $3.27 $8,027 - $11,615	-3,552 Reduced 0.59%	600,741 $0
Q2 2018 Aug 06, 2018	SELL	$3.02 - $4.94 $46,924 - $76,757	-15,538 Reduced 2.51%	604,293 $1.83 Million
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $25,936 - $38,529	7,496 Added 1.22%	619,831 $2.43 Million
Q4 2017 Feb 09, 2018	BUY	$4.0 - $6.54 $2.45 Million - $4 Million	612,335	612,335 $2.54 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account